Eloxx Pharmaceuticals, Inc. (ELOX)
0.37
+0.01
(+2.78%)
USD |
OTCM |
May 29, 16:00
Eloxx Pharmaceuticals Shareholders Equity (Quarterly) : -7.584M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 68.14M |
| CorMedix, Inc. | 437.05M |
| Cannabis Global, Inc. | -4.772M |
| Breakthrough Chemistry, Inc. | 1.841M |
| BioStem Technologies, Inc. | 31.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.503M |
| Total Liabilities (Quarterly) | 16.09M |
| Current Ratio | 0.4758 |
| Net Debt Paydown Yield | 654.3% |